European equities traded in the US as American depositary receipts opened the week modestly higher late Monday morning, increasing 0.22% to 1,548.79 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biopharmaceutical company Genfit (GNFT) and internet browser company Opera (OPRA), which rose 5.9% and 5.7%, respectively. They were followed by semiconductor company Sequans Communications (SQNS) and biopharmaceutical company Grifols (GRFS), which were up 4.6% and 1.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and medical device maker EDAP TMS (EDAP), which shed 22% and 2.4%, respectively. They were followed by petroleum refiner Equinor (EQNR) and oil and gas company TotalEnergies (TTE), which fell 2.3% and 1.6%, respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical companies Adaptimmune Therapeutics (ADAP) and Bicycle Therapeutics (BCYC), which climbed 8.8% and 3.4%, respectively. They were followed by biotech firm Autolus Therapeutics (AUTL) and biopharmaceutical company Akari Therapeutics (AKTX), which advanced 3.2% and 2%, respectively.

The decliners from the UK and Ireland were led by cruise line operator Carnival (CUK) and oil and gas company BP (BP), which dropped 2.8% and 2.1%, respectively. They were followed by tobacco company British American Tobacco (BTI) and oil and gas company Shell (SHEL), which were down 1.2% and 1.1%, respectively.